TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Steven Mah

Managing Director, Health Care - Life Science & Diagnostic Tools

Headshot photo of Steven Mah

Steven Mah is a Managing Director on the Equity Research team in the life science & diagnostic tools sector. Prior to joining TD Cowen, Dr. Mah was a senior analyst for life science & diagnostic tools at Piper Sandler, and earlier in his career was a Principal in Piper Sandler’s health care investment banking group, where he focused on mergers and acquisitions as well as equity and equity-linked transactions.

At TD Cowen his expertise in dynamic emerging market segments such as synthetic biology and artificial-intelligence driven health solutions will further the health care research sector.

Dr. Mah holds a B.S. in molecular biology from the University of California, Los Angeles; a Ph.D. in molecular biology from the University of California, San Diego; and an MBA from Cornell University’s Johnson Graduate School of Management.

Get In Touch

Start a conversation with Steven Mah


    Explore related thought leadership, reports, coverage and insights for Steven Mah.

    Robotic arm holding out a generic pill bottle.

    AI Designing Drugs: Navigating the Hype

    Biochemist in lab wearing lab coat. blue gloves, and goggles is looking at a blue liquid solution in a glass flask.
    Ahead of the Curve®

    Liquid Biopsy: 10 Years In & We’ve Only Just Begun

    A young female researcher in a lab coat is conducting research on a computer.
    Ahead of the Curve®

    AI In Drug Development: From Hype To The Clinic & Beyond